James A Johnson - Net Worth and Insider Trading
James A Johnson Net Worth
The estimated net worth of James A Johnson is at least $2,689 dollars as of 2024-09-20. James A Johnson is the Director of Athira Pharma Inc and owns about 5,000 shares of Athira Pharma Inc (ATHA) stock worth over $2,324. James A Johnson is also the CFO of NS Wind Down Co Inc and owns about 5,089 shares of NS Wind Down Co Inc (NSTGQ) stock worth over $365. Details can be seen in James A Johnson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James A Johnson has not made any transactions after 2023-03-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James A Johnson
James A Johnson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James A Johnson owns 2 companies in total, including Athira Pharma Inc (ATHA) , and NS Wind Down Co Inc (NSTGQ) .
Click here to see the complete history of James A Johnson’s form 4 insider trades.
Insider Ownership Summary of James A Johnson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATHA | Athira Pharma Inc | 2023-03-29 | director |
| NSTGQ | NS Wind Down Co Inc | 2016-11-11 | Chief Financial Officer |
James A Johnson Latest Holdings Summary
James A Johnson currently owns a total of 2 stocks. Among these stocks, James A Johnson owns 5,000 shares of Athira Pharma Inc (ATHA) as of March 29, 2023, with a value of $2,324 and a weighting of 86.42%. James A Johnson also owns 5,089 shares of NS Wind Down Co Inc (NSTGQ) as of November 11, 2016, with a value of $365 and a weighting of 13.58%.
Latest Holdings of James A Johnson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATHA | Athira Pharma Inc | 2023-03-29 | 5,000 | 0.46 | 2,324 |
| NSTGQ | NS Wind Down Co Inc | 2016-11-11 | 5,089 | 0.07 | 365 |
Holding Weightings of James A Johnson
James A Johnson Form 4 Trading Tracker
According to the SEC Form 4 filings, James A Johnson has made a total of 1 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Athira Pharma Inc is the acquisition of 5,000 shares on March 29, 2023, which cost James A Johnson around $12,000.
According to the SEC Form 4 filings, James A Johnson has made a total of 0 transactions in NS Wind Down Co Inc (NSTGQ) over the past 5 years. The most-recent trade in NS Wind Down Co Inc is the sale of 10,000 shares on November 11, 2016, which brought James A Johnson around $225,700.
Insider Trading History of James A Johnson
- 1
James A Johnson Trading Performance
GuruFocus tracks the stock performance after each of James A Johnson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James A Johnson is 22.78%. GuruFocus also compares James A Johnson's trading performance to market benchmark return within the same time period. The performance of stocks bought by James A Johnson within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James A Johnson's insider trading performs compared to the benchmark.
Performance of James A Johnson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.72 | | | | | |
| Relative Return to S&P 500(%) | 14.2 | | | | | |
James A Johnson Ownership Network
James A Johnson Owned Company Details
What does Athira Pharma Inc do?
Who are the key executives at Athira Pharma Inc?
James A Johnson is the director of Athira Pharma Inc. Other key executives at Athira Pharma Inc include See Below Andrew Gengos , Chief Operating Officer Mark James Litton , and Vice President of Discovery Kevin Church .
Athira Pharma Inc (ATHA) Insider Trades Summary
Over the past 18 months, James A Johnson made 1 insider transaction in Athira Pharma Inc (ATHA) with a net purchase of 5,000. Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net purchase of 77,532 shares made by Andrew Gengos , a net sale of 14,672 shares made by Mark James Litton , and a net sale of 7,349 shares made by Mark Worthington .
In summary, during the past 3 months, insiders sold 13,879 shares of Athira Pharma Inc (ATHA) in total and bought 42,400 shares, with a net purchase of 28,521 shares. During the past 18 months, 36,787 shares of Athira Pharma Inc (ATHA) were sold and 758,098 shares were bought by its insiders, resulting in a net purchase of 721,311 shares.
Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athira Pharma Inc Insider Transactions
James A Johnson Mailing Address
Above is the net worth, insider trading, and ownership report for James A Johnson. You might contact James A Johnson via mailing address: C/o Zymogenetics, Inc., 1201 Eastlake Avenue, Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
